1. Home
  2. CRDO vs RGEN Comparison

CRDO vs RGEN Comparison

Compare CRDO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credo Technology Group Holding Ltd

CRDO

Credo Technology Group Holding Ltd

HOLD

Current Price

$144.36

Market Cap

34.2B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$157.57

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDO
RGEN
Founded
2008
1981
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2B
8.2B
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CRDO
RGEN
Price
$144.36
$157.57
Analyst Decision
Strong Buy
Buy
Analyst Count
12
10
Target Price
$179.91
$170.90
AVG Volume (30 Days)
7.4M
696.6K
Earning Date
12-01-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.11
0.03
Revenue
$796,128,000.00
$707,890,000.00
Revenue This Year
$127.02
$17.84
Revenue Next Year
$28.18
$12.57
P/E Ratio
$129.46
$6,185.26
Revenue Growth
224.17
11.74
52 Week Low
$29.09
$102.97
52 Week High
$213.80
$182.52

Technical Indicators

Market Signals
Indicator
CRDO
RGEN
Relative Strength Index (RSI) 41.02 47.50
Support Level $176.00 $160.11
Resistance Level $213.80 $165.02
Average True Range (ATR) 13.51 4.97
MACD -2.48 -1.27
Stochastic Oscillator 9.58 7.12

Price Performance

Historical Comparison
CRDO
RGEN

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: